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1. Introduction {#efs26072-sec-0002}
===============

1.1. Background and Terms of Reference as provided by the requestor {#efs26072-sec-0003}
-------------------------------------------------------------------

Regulation (EC) No 1831/2003[1](#efs26072-note-1007){ref-type="fn"} establishes the rules governing the Community authorisation of additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an application in accordance with Article 7. In addition, Article 14(1) of that Regulation lays down that an application for renewal shall be sent to the Commission at the latest one year before the expiry date of the authorisation.

The European Commission received a request from Kyowa Hakko Europe GmbH[2](#efs26072-note-1008){ref-type="fn"} for renewal of the authorisation of the product [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by *Escherichia coli* NITE SD 00268 when used as a feed additive for salmonids (category: nutritional additive; functional group: amino acids, their salts and analogues) and for authorisation when used as feed additive for fish other than salmonids (category: nutritional additive; functional group: amino acids, their salts and analogues).

According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the application to the European Food Safety Authority (EFSA) as an application under Article 4(1) (authorisation of a feed additive or new use of a feed additive) and under Article 14(1) (renewal of the authorisation). The particulars and documents in support of the application were considered valid by EFSA as of 22 July 2016 for FAD‐2016‐0020 and as of 20 August 2018 for FAD‐2018‐0039.

According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and documents submitted by the applicant, shall undertake an assessment in order to determine whether the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the safety for the target animals, consumer, user and the environment and on the efficacy of the product [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by *E. coli* NITE SD 00268, when used under the proposed conditions of use (see Section [3.1.6](#efs26072-sec-0015){ref-type="sec"}).

1.2. Additional information {#efs26072-sec-0004}
---------------------------

[l]{.smallcaps}‐Histidine monohydrochloride monohydrate minimum 98% produced by *E. coli* NITE SD 00268 is the subject of the present assessment. The active substance of the product under application is [l]{.smallcaps}‐histidine. This additive has been previously assessed as nutritional feed additive (amino acid) for salmonids by the FEEDAP Panel (EFSA, [2005](#efs26072-bib-0014){ref-type="ref"}, [2006a](#efs26072-bib-0015){ref-type="ref"}) but as a product ■■■■■ of *E. coli* ATCC 21318. [l]{.smallcaps}‐Histidine monohydrochloride monohydrate minimum 98% produced by *E. coli* ATCC 9637 is currently listed in the European Union Register of Feed Additives, and thus authorised in the European Union for use in feed for salmonids.[3](#efs26072-note-1009){ref-type="fn"}

[l]{.smallcaps}‐Histidine, ■■■■■ is currently listed in the European Union Register of Feed Additives, and authorised in the European Union as a feed flavouring for all animal species.[4](#efs26072-note-1010){ref-type="fn"} The FEEDAP Panel (EFSA FEEDAP Panel, [2014](#efs26072-bib-0023){ref-type="ref"}) assessed the safety and efficacy of [l]{.smallcaps}‐histidine as feed flavouring compound. The FEEDAP Panel has published several opinions on the safety and efficacy of [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by fermentation for all animal species (EFSA FEEDAP Panel, [2019a](#efs26072-bib-0029){ref-type="ref"},[b](#efs26072-bib-0030){ref-type="ref"},[c](#efs26072-bib-0031){ref-type="ref"}). [l]{.smallcaps}‐Histidine as a flavouring agent was assessed by the Joint FAO/WHO Expert Committee on Food Additives (JECFA, [2004](#efs26072-bib-0802){ref-type="ref"}) and was considered safe for use in food. The EFSA\'s Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) evaluated [l]{.smallcaps}‐histidine and considered it safe for use as flavours in food (EFSA, [2006b](#efs26072-bib-0016){ref-type="ref"}, [2008a](#efs26072-bib-0017){ref-type="ref"},[b](#efs26072-bib-0018){ref-type="ref"}; EFSA CEF Panel [2011](#efs26072-bib-0021){ref-type="ref"}).

[l]{.smallcaps}‐Histidine is authorised for use in food,[5](#efs26072-note-1011){ref-type="fn"} cosmetics[6](#efs26072-note-1012){ref-type="fn"} and as a veterinary medicinal product.[7](#efs26072-note-1013){ref-type="fn"} ^,^ [8](#efs26072-note-1014){ref-type="fn"}

The Panel on nutrition, dietetic products, novel food and allergy of the Norwegian Scientific Committee for Food Safety (VKM, [2016](#efs26072-bib-0060){ref-type="ref"}) issued a scientific opinion on [l]{.smallcaps}‐histidine in food supplements and energy drinks sold in Norway and concluded that doses 550 and 600 mg/day [l]{.smallcaps}‐histidine in food supplements are unlikely to cause adverse health effects in humans ≥ 10 years of age.

[l]{.smallcaps}‐Histidine HCl monohydrate is described in a monograph of the European Pharmacopoeia (PhEur 9th edition, 2017): monograph 01/2005:0910.

[l]{.smallcaps}‐Histidine monohydrochloride monohydrate that is currently authorised for salmonids is produced by *E. coli* ATCC 21318 (inaccurately identified with the parental strain ATCC 9637 in Regulation (EC) 244/2007 and derived from it by one mutagenesis step). The applicant has requested for a change in the production strain from *E. coli* ATCC 21318 to *E. coli* NITE SD 00268.

2. Data and methodologies {#efs26072-sec-0005}
=========================

2.1. Data {#efs26072-sec-0006}
---------

The present assessment is based on data submitted by the applicant in the form of a technical dossier[9](#efs26072-note-1015){ref-type="fn"} in support of the renewal of the authorisation for the use of [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by *E. coli* NITE SD 00268 as a feed additive for salmonids, and the extension of the authorisation to other fin fish.

The FEEDAP Panel used the data provided by the applicant together with data from other sources, such as previous risk assessments by EFSA or other expert bodies, peer‐reviewed scientific papers, other scientific reports and experts' knowledge, to deliver the present output.

The European Union Reference Laboratory (EURL) considered that the conclusions and recommendations reached in the previous assessment regarding the methods used for the control of [l]{.smallcaps}‐histidine monohydrochloride monohydrate in animal feed are valid and applicable for the current application.[10](#efs26072-note-1016){ref-type="fn"}

2.2. Methodologies {#efs26072-sec-0007}
------------------

The approach followed by the FEEDAP Panel to assess the safety and the efficacy of [l]{.smallcaps}‐histidine monohydrochloride monohydrate minimum 98% produced using *E. coli* NITE SD 00268 is in line with the principles laid down in Regulation (EC) No 429/2008[11](#efs26072-note-1017){ref-type="fn"} and the relevant guidance documents: Guidance on the identity, characterisation and conditions of use of feed additives (EFSA FEEDAP Panel, [2017a](#efs26072-bib-0024){ref-type="ref"}), Guidance on the characterisation of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, [2018a](#efs26072-bib-0027){ref-type="ref"}), Guidance on the assessment of the safety of feed additives for the target species (EFSA FEEDAP Panel, [2017b](#efs26072-bib-0025){ref-type="ref"}), Guidance on the assessment of the safety of feed additives for the consumer (EFSA FEEDAP Panel, [2017c](#efs26072-bib-0026){ref-type="ref"}), Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, [2012](#efs26072-bib-0022){ref-type="ref"}), Guidance on the assessment of the safety of feed additives for the environment (EFSA FEEDAP Panel, [2019d](#efs26072-bib-0032){ref-type="ref"}) and Guidance on the assessment of the efficacy of feed additives (EFSA FEEDAP Panel, [2018b](#efs26072-bib-0028){ref-type="ref"}).

3. Assessment {#efs26072-sec-0008}
=============

This assessment regards the renewal of the authorisation of the additive [l]{.smallcaps}‐histidine monohydrochloride monohydrate (minimum 98%) produced by *E. coli* NITE SD 00268 as nutritional additive (functional group: amino acids, their salts and analogues) for salmonids. The applicant is also requesting the extension of the authorisation to other fin fish as a nutritional feed additive (functional group: amino acids, their salts and analogues). The FEEDAP Panel notes that the production strain has been changed; therefore, this assessment deals also with the characterisation of the new strain.

3.1. Characterisation {#efs26072-sec-0009}
---------------------

### 3.1.1. Characterisation of the production organism {#efs26072-sec-0010}

According to Regulation (EC) 244/2007, [l]{.smallcaps}‐histidine monohydrochloride monohydrate approved for use in salmonids is produced by *E. coli* ATCC 9637. The strain ATCC 9637 was inaccurately identified as the production strain in the 2007 authorisation because it was actually the parental strain. The proper production strain of the authorised additive was *E. coli* ATCC 21318■■■■■

The applicant has now requested to use another *E. coli* [l]{.smallcaps}‐histidine production strain -- as compared to the production strain of the [l]{.smallcaps}‐histidine already authorised -- that has been deposited in the Biological resource Centre of the Japanese National Institute of Technology and Evaluation with the deposition number NITE SD 00268.[12](#efs26072-note-1018){ref-type="fn"} ■■■■■

■■■■■

The morphological characteristics of the production strain are provided in the technical dossier.[13](#efs26072-note-1019){ref-type="fn"} The production strain, ■■■■■ does not raise concerns regarding its capacity to produce substances with antimicrobial activity ■■■■■ or toxins.[14](#efs26072-note-1020){ref-type="fn"} In addition, supporting evidence on the absence of antimicrobial activity in the end product was provided in a test demonstrating no growth inhibition of a *Bacillus subtilis* strain used as the test organism.[15](#efs26072-note-1021){ref-type="fn"}

■■■■■[■■■■■](#efs26072-note-2017){ref-type="fn"}■■■■■[■■■■■](#efs26072-note-2018){ref-type="fn"}

### 3.1.2. Manufacturing process {#efs26072-sec-0011}

■■■■■[■■■■■](#efs26072-note-2019){ref-type="fn"}■■■■■[■■■■■](#efs26072-note-2021){ref-type="fn"}

The applicant stated that no antimicrobial compounds are used during the production process.[20](#efs26072-note-1022){ref-type="fn"}

### 3.1.3. Characterisation of the active substance/additive {#efs26072-sec-0012}

[l]{.smallcaps}‐Histidine monohydrochloride monohydrate (International Union of Pure and Applied Chemistry (IUPAC) name: (2*S*)‐2‐amino‐3‐(1*H*‐imidazol‐5‐yl)propanoic acid hydrate hydrochloride), is a compound identified with the Chemical Abstract Service (CAS) No 5934‐29‐2, and the European Inventory of Existing Commercial Chemical Substances (EINECS) No 211‐438‐9. It has a molecular weight of 209.63 Da. The chemical formula of [l]{.smallcaps}‐histidine monohydrochloride monohydrate is C~6~H~9~N~3~O~2~.HCl.H~2~O. The structural formula is given in Figure [1](#efs26072-fig-0001){ref-type="fig"}.

![Structural formula of [l]{.smallcaps}‐histidine monohydrochloride monohydrate](EFS2-18-e06072-g001){#efs26072-fig-0001}

The additive is currently authorised with a minimum content of 98% [l]{.smallcaps}‐histidine HCl monohydrate and \< 1% moisture. (Regulation (EC) 244/2007). Analysis of five batches confirmed compliance with these specifications and showed an average [l]{.smallcaps}‐histidine content of 74.1% *as is* (range 72.3--74.7%),[21](#efs26072-note-1023){ref-type="fn"} equivalent to approximately 100% [l]{.smallcaps}‐histidine HCl monohydrate (the proportion of HCl and water by stoichiometric calculation is of 26%). The amount of unidentified substances on dry matter basis was \< 1%.

The specific optical rotation of the additive was measured in three batches and it was +9.9 in all cases.[22](#efs26072-note-1024){ref-type="fn"} It is within the range (+9.2 to +10.6˚) of the European Pharmacopoeia ([2017](#efs26072-bib-0034){ref-type="ref"}) and confirms the [l]{.smallcaps}‐stereoisomer of histidine.

**Impurities**

The analyses of three batches of the additive for heavy metals (lead, mercury and cadmium) and arsenic (three batches analysed) showed values below the limits of detection (LODs).[23](#efs26072-note-1025){ref-type="fn"} Sodium ranged from 0.5 to 2 g/kg, potassium from 4.7 to 5.9 mg/kg and iron from 1.0 to 1.6 mg/kg. Dioxins (PCDD/F) and dioxin‐like PCBs were measured in three batches of the final product. In all cases, the measured value was 0.1 pg bioanalytical equivalents (BEQ)/g fat, corresponding to the limit of detection.[24](#efs26072-note-1026){ref-type="fn"}

■■■■■[■■■■■](#efs26072-note-2027){ref-type="fn"}

■■■■■

The absence of viable cells of the production strain was demonstrated in 1.2 g sample from three batches (tested in triplicate) by spreading on selective agar plates and incubation for three days at 32°C. The positive control (spiked with bacterial broth) yielded a positive result.[26](#efs26072-note-1027){ref-type="fn"}

The absence of DNA from the production strain in the additive■■■■■ was confirmed by polymerase chain reaction (PCR) ■■■■■[■■■■■](#efs26072-note-2030){ref-type="fn"}

**Physico‐chemical characteristics**

The additive is a greyish white to greyish brown crystalline powder or granules.[28](#efs26072-note-1028){ref-type="fn"} Its tapped bulk density (three batches analysed) ranged from 0.92 to 1.04 g/cm^3^.[29](#efs26072-note-1029){ref-type="fn"} Its pH ranged from 3.5 to 4.5 (10% solution in water).[30](#efs26072-note-1030){ref-type="fn"}

The dusting potential of the additive (Stauber--Heubach method) analysed in three batches ranged from 4.7 to 5.8 g/m^3^.[31](#efs26072-note-1031){ref-type="fn"} Particle size distribution (volume based, three batches) was measured by laser diffraction and ranged from about 200 to 900 μm of diameter; no particles of \< 100 μm of diameter were found.[32](#efs26072-note-1032){ref-type="fn"} The particle size of the dust of the additive ranged from 2 μm to 26--32 μm diameter (10th and 99th percentiles).[33](#efs26072-note-1033){ref-type="fn"}

### 3.1.4. Stability and homogeneity {#efs26072-sec-0013}

The shelf‐life of three batches of the additive was studied when stored at 40°C for 6 months;[34](#efs26072-note-1034){ref-type="fn"} packaging was not described. Only tabulated results were provided (no certificates of analysis). At the end of the storage period, losses of [l]{.smallcaps}‐histidine ranged from 0 to 4%.

The shelf‐life of three batches of the additive was studied when stored in polyethylene bags at 25 ± 2°C for three years;[35](#efs26072-note-1035){ref-type="fn"} losses ranged from 0 to 0.6%.

The stability of the additive (one batch) when supplemented at 0.8% (calculated) was estimated in a salmon feed (based on fish meal, soy protein concentrate, wheat, rapeseed oil and fish oil) in mash, extruded feed (20 bar, 110--130°C) and fat coated extruded feed, stored in polyethylene bottles at room temperature for 3 months.[36](#efs26072-note-1036){ref-type="fn"} Total histidine was measured and corrected for basal levels of histidine HCl present in the corresponding sample. No losses were observed at the end of the storage period in any of those feed forms.

The capacity of the additive to distribute homogeneously in feed was studied in the two types of extruded feed for salmon described above by analysing 10 subsamples.[37](#efs26072-note-1037){ref-type="fn"} The coefficient of variation of the calculated added histidine (total histidine after supplementation minus histidine in basal diet) was 5.6% in the pelleted feed and 2.4% in the fat coated pelleted feed.

### 3.1.5. Physico‐chemical incompatibilities in feed {#efs26072-sec-0014}

No physico‐chemical incompatibilities in feed are expected when used with other additives, medicinal products or other feed materials.

### 3.1.6. Conditions of use {#efs26072-sec-0015}

[l]{.smallcaps}‐Histidine monohydrochloride monohydrate is currently authorised as a nutritional additive, functional group 'amino acids, their salts and analogues' for salmonids with no minimum or maximum content specified. The applicant proposes a maximum total concentration of histidine in feed for salmonids of 1.7%.[38](#efs26072-note-1038){ref-type="fn"}

In addition, the applicant is proposing the extension of use to feed for fin fish other than salmonids with a maximum content of 1.7% total histidine in feed. The need of supplementing [l]{.smallcaps}‐histidine HCl monohydrate generally depends on the requirement of the animal species/categories and the background content of this essential amino acid in feedingstuffs. The additive is proposed to be supplemented directly into feedingstuffs (complete or complementary feed) or via premixtures.[38](#efs26072-note-1038){ref-type="fn"}

3.2. Safety {#efs26072-sec-0016}
-----------

### 3.2.1. Safety of the production microorganism {#efs26072-sec-0017}

The production strains *E. coli* NITE SD 00268 (under assessment) and *E. coli* ATCC 21318 (previously assessed) are derived from the same parental strain *E. coli* ATCC 9637, which is considered to be safe. The identity of the production strain *E. coli* NITE SD 00268 ■■■■■ has been established, the strain does not harbour acquired antimicrobial resistant genes and no viable cells or DNA were detected in the final product. Therefore, the use of *E. coli* NITE SD 00268 to produce [l]{.smallcaps}‐histidine monohydrochloride monohydrate does not give rise to safety concerns.

### 3.2.2. Absorption, distribution, metabolism and excretion {#efs26072-sec-0018}

The applicant provided a review of the metabolic fate of [l]{.smallcaps}‐histidine.[39](#efs26072-note-1039){ref-type="fn"} It is rapidly and extensively absorbed by animals. Transport across membranes by intestinal enterocytes can occur by diffusion or by active transport, and these processes are usually sodium‐dependent (Webb, [1990](#efs26072-bib-0062){ref-type="ref"}; WHO, [2006](#efs26072-bib-0064){ref-type="ref"}). [l]{.smallcaps}‐Histidine mostly enters cells unchanged.

[l]{.smallcaps}‐histidine may be incorporated into proteins or biologically important dipeptides by the animal (WHO, [2006](#efs26072-bib-0064){ref-type="ref"}; Bellia et al., [2008](#efs26072-bib-0007){ref-type="ref"}). The FEEDAP Panel notes that histidine is different from other essential amino acids in that substantial quantities exist in haemoglobin and in the form of free imidazol derivatives (dipeptides) in animal muscle tissues such as carnosine (β‐alanyl histidine), anserine (β‐alanyl‐1‐methyl histidine) and balenine (β‐alanyl‐3‐methyl histidine) leading to the difficulty of establishing conclusive indispensability. Furthermore, these dipeptides have anti‐inflammatory and antioxidant effects; it is believed that they interact with oxygen radicals and lipid peroxidation products to prevent membrane damage (Buttery and D\'Mello, [1994](#efs26072-bib-0012){ref-type="ref"}; Onodera, [2003](#efs26072-bib-0056){ref-type="ref"}).

Where [l]{.smallcaps}‐histidine is not required for protein or peptide synthesis, it can be degraded by oxidation and transamination (Wade and Tucker, [1998](#efs26072-bib-0061){ref-type="ref"}; Nelson and Cox, [2008](#efs26072-bib-0052){ref-type="ref"}). α‐Ketoglutarate is formed as a degradation product which enters the citric acid cycle leading to further metabolic intermediates. Following [l]{.smallcaps}‐histidine loading, unchanged histidine as well as these normal metabolic intermediates are detected in the urine. [l]{.smallcaps}‐Histidine is also a precursor for histamine, produced by the enzyme histidine decarboxylase, present in e.g. brain and gut tissues and in gut microbiota.

### 3.2.3. Safety for the target species {#efs26072-sec-0019}

The product under assessment is produced by fermentation using a non‐genetically modified strain of *E. coli* W type derivative that is considered safe (see Section [3.2.1](#efs26072-sec-0017){ref-type="sec"}). No cells of the production strain were found in the final product. Moreover, endotoxin activity of the product (\< 100 IU/g) is considered low and of no concern for the target species. The FEEDAP Panel considers that no safety concerns would derive from the fermentation process. The additive contains ≥ 98% [l]{.smallcaps}‐histidine HCl monohydrate and the amount of unidentified material is \< 1%.

The FEEDAP Panel notes that [l]{.smallcaps}‐histidine chelates divalent metal ions; and is necessary for the regulation and catabolism of trace elements such as zinc, copper, iron, manganese and molybdenum. High levels of histidine may therefore theoretically cause deficiencies of the free forms of these metal ions due to increased excretion (Ketola, [1979](#efs26072-bib-0046){ref-type="ref"}; Aoyama et al., [1992](#efs26072-bib-0004){ref-type="ref"}; Aoyama et al., [2000](#efs26072-bib-0800){ref-type="ref"}; Glover and Hogstrand, [2002](#efs26072-bib-0041){ref-type="ref"}; Breck et al., [2003](#efs26072-bib-0009){ref-type="ref"}; VKM, [2016](#efs26072-bib-0060){ref-type="ref"}).

#### 3.2.3.1. Safety for salmonids {#efs26072-sec-0020}

In its previous opinion, the FEEDAP Panel noted that there was limited scientific information on the use of excess dietary crystalline histidine in salmonids (EFSA, [2005](#efs26072-bib-0014){ref-type="ref"}). Based on a 6‐month study on Atlantic salmon where dietary histidine levels up to 1.7% showed no adverse effects on fish growth and health the FEEDAP Panel concluded that the additive was safe for salmonids up to 1.7%.

The National Research Council (NRC) has established histidine requirements (% of the diet) for Atlantic salmon (0.8%), Pacific salmon (0.7%) and Rainbow trout (0.8%) (NRC, [2011](#efs26072-bib-0054){ref-type="ref"}).

The applicant reviewed the scientific literature aiming to identify studies in which [l]{.smallcaps}‐histidine HCl monohydrate was supplemented into feed as confirmation of the suitability of the additive as available histidine source.[40](#efs26072-note-1040){ref-type="fn"} The literature search was performed using Google Scholar and the keywords applied were 'histidine' combined with 'fish, salmon, trout, bass, shellfish and shrimp'; the inclusion criterium was 'studies in which histidine was supplemented to fish feed'. The FEEDAP Panel notes that the literature search had some limitations: only a single database was searched, the keywords did not include the terms 'safety' or 'toxicity' and the total number of hits and exclusion criteria were not reported; these hindrances cast doubts on the adequacy of the literature search performed to support the safety for the target species.

Nine scientific reports testing the effects of [l]{.smallcaps}‐histidine in fish diets (mainly Atlantic salmon but also carp, rainbow trout and Nile tilapia) were selected by the applicant. Only those performed in salmonids were assessed by the FEEDAP Panel: Breck et al. ([2003](#efs26072-bib-0009){ref-type="ref"}, [2005a](#efs26072-bib-0010){ref-type="ref"},[b](#efs26072-bib-0011){ref-type="ref"}), Remø et al. ([2014](#efs26072-bib-0057){ref-type="ref"}); Roland et al. ([2015](#efs26072-bib-0058){ref-type="ref"}) and Taylor et al. ([2015](#efs26072-bib-0059){ref-type="ref"}).[41](#efs26072-note-1041){ref-type="fn"}

Breck et al. ([2003](#efs26072-bib-0009){ref-type="ref"}, [2005a](#efs26072-bib-0010){ref-type="ref"}) showed that low levels of histidine and *N*‐acetylhistidine in eye lens are associated with cataract development in *Salmo salar* L. and confirmed that it could be significantly mitigated by dietary histidine (1.4% histidine versus a control diet with 0.9% histidine) when fed for 23 weeks. In a subsequent experiment (Breck et al., [2005b](#efs26072-bib-0011){ref-type="ref"}), the effect of dietary histidine and iron on cataract development of two strains of Atlantic salmon monitored through parr‐smolt transformation was studied. Histidine diets (1.8% histidine vs. 1.2% histidine in control diet) fed for 26 weeks significantly reduced cataract development and significantly increased body weight (BW) and feed intake (FI). A significant genetic influence on the development of cataracts was also detected.

Remø et al. ([2014](#efs26072-bib-0057){ref-type="ref"}) investigated if dietary histidine requirements to reduce cataract development were higher than those to grow in Atlantic salmon (*Salmo salar* L) smolts after seawater transfer. Diets containing increasing histidine concentrations (1, 1.2, 1.4, 1.5 and 1.8%) were fed for 13 weeks after seawater transfer. Dietary histidine concentration did not affect weight gain. Lowest severity of cataracts was achieved at 1.3% histidine.

Taylor et al. ([2015](#efs26072-bib-0059){ref-type="ref"}) studied the effect of increasing levels of dietary histidine (1.3 or 1.7%) on cataract development of diploid or triploid Atlantic salmon when growing in seawater (post‐moults). Experimental diets were administered for 3 months. Dietary histidine did not significantly affect weight or growth rate within ploidy, but improved feed conversion ratio (FCR) in triploid fish fed 1.7% histidine.

Roland et al. ([2015](#efs26072-bib-0058){ref-type="ref"}) studied the effect of plant proteins and amino acid supplementation on plasma amino acid profiles (monitored from 2 to 42 h after feed intake) and metabolism of rainbow trout (*Oncorhynchus mykiss*) of 470 g initial BW. Levels of histidine were 0.9% (fish meal), 0.8% (pea protein concentrate) and 1.4% (pea protein concentrate supplemented with histidine, lysine, methionine and threonine to mimic fish meal). The diet with supplemental amino acids resulted in greater and faster rises of plasmatic concentrations followed by sharp decreases compared with the diet containing fish meal. The effect on performance was not studied.

From these studies, it can be concluded that high levels of histidine in feed (up to 1.7%, representing about twice the requirements) are needed to prevent cataract in Atlantic salmon and these levels have no adverse effects on performance in this species. There is a positive relationship between dietary histidine concentration and histidine, anserine and carnosine deposition in fish flesh of Atlantic salmon. Supplemental histidine may result in a faster absorption compared to diets containing protein‐bound histidine, resulting in peaks in the plasmatic amino acid profile. An additional issue that was not considered by the applicant is related to the possibility that high [l]{.smallcaps}‐histidine supplementation may lead to interaction with essential metals such as zinc with possible adverse metabolic consequences for the salmonids (see Section [3.2.3](#efs26072-sec-0019){ref-type="sec"}).

Notwithstanding the limitations on the literature search described and the data therein reported, the FEEDAP Panel considers that the data provided in the studies reviewed support the conclusions reached in the previous opinion of the FEEDAP Panel that the additive is safe for salmonids up to 1.7% histidine in the diet (EFSA, [2005](#efs26072-bib-0014){ref-type="ref"}). The maximum total content of histidine in feed proposed by the applicant is in line with this conclusion.

#### 3.2.3.2. Safety for fin fish other than salmonids {#efs26072-sec-0021}

The requirements of histidine (% of the diet) established by NRC ([2011](#efs26072-bib-0054){ref-type="ref"}) for fish other than salmonids are limited to some species: 0.5% for the common carp (*Cyprinus carpio*), 0.9% for mrigal carp (*Cirrhinus mrigala*), 0.9% for rohu (*Labeo rohita*), 1.0% for Nile tilapia (*Oreochromis niloticus*) and 0.6% for channel catfish (*Ictalurus punctatus*).

The applicant conducted a literature search in Web of Knowledge database to identify adverse effects related to histidine in diets of fish other than salmonids.[42](#efs26072-note-1042){ref-type="fn"} Key words used were 'histidine' in combination with 'fish NOT salmon NOT trout', carp, Cyprinus, tilapia, Oreochromis, bass, Micropterus, tuna, Thunnini, mackerel or scomber. A total of 806 hits were retrieved and title/abstracts screened for relevance. Fifteen studies were selected: seven for carp (two of them, however, were available only in abstract form and were not further considered), four for catfish, and one for each of the following fish species: flounder (*Paralichthys olivaceous*), croaker (*Pseudosciaena crocea*), Nile tilapia and yellowtail fish. Those studies are described below.

Regarding African catfish (*Clarias gariepinus* \[Burchel\]), Khan and Abidi ([2009](#efs26072-bib-0047){ref-type="ref"}) tested the effect of increasing levels of dietary histidine (0.25--0.50% histidine in diet on dry matter (DM)) on performance of fries when fed for 12 weeks. Best performance was achieved at 0.40% histidine in diet. The highest level resulted in significant differences increasing FCR and decreasing absolute weight gain, protein efficiency ratio (PER) and specific growth ratio (SGR) in comparison to the group treated with 0.40% histidine.

As per Indian catfish (*Heteropneustes fossilis* \[Bloch\]), three studies (fingerlings or fry) were submitted (Ahmed, [2013](#efs26072-bib-0002){ref-type="ref"}; Farhat and Kan, [2013](#efs26072-bib-0037){ref-type="ref"}; Khan and Abidi, [2014](#efs26072-bib-0048){ref-type="ref"}) studying the effect of increasing levels of histidine in the diet (0.25--0.75%; 0.5--1.25%; or 1--2%, respectively) on performance and blood parameters when fed for 8--12 weeks. The best results were obtained within a wide range of dietary histidine concentrations (0.5--1.6%, depending on the study considered) with performance parameters significantly worsening at the highest histidine level of the respective study.

Regarding Asian carp (*Cirrhinus mrigala* \[Hamilton\]), Ahmed and Khan ([2005](#efs26072-bib-0003){ref-type="ref"}) studied the dietary requirements of the fingerlings by surveying the effect of increasing dietary histidine levels (0.25--1.5%) on performance parameters (final BW, body weight gain (BWG), SGR, FCR and PER), when fed for 8 weeks. Performance parameters were optimised at 0.75% histidine and significantly decreased (except FCR that increased) from 1% histidine dietary concentration.

As per juvenile Asian grass carp (*Ctenopharyngodon Idella*), Gao et al. ([2016](#efs26072-bib-0040){ref-type="ref"}) studied the effects of increasing dietary histidine levels (0.45--1.78% DM feed) fed during 10 weeks on performance parameters, enzymatic intestinal activity, erythrocyte osmolar fragility and hypoxia tolerance. Histidine concentration in fish flesh increased in a concentration‐dependent manner (2.4% and 3.3% at lowest and highest dietary histidine concentrations respectively). Performance (final BW and BWG) was optimised at 1.02% dietary histidine and significantly decreased in the next higher histidine concentration tested (1.6%).

Zhera and Khan (2014) studied the effects of increasing dietary histidine levels (0.25--0.96%) in fingerlings of South Asian carp (*Catla catla* \[Hamilton\]) fed for 12 weeks on performance parameters, carcass composition and haematological parameters. Optimised results on final BW, FCR, FI and protein gain were obtained at the range of 0.63--0.68% histidine in DM diet and no significant differences were observed at the highest dose tested (0.96%).

The effect of histidine supplementation of juvenile (9 g initial BW) European carp (*Cyprinus carpio* var. Jian) on performance parameters and intestinal enzymatic activity was studied by Zhao et al. ([2012](#efs26072-bib-0067){ref-type="ref"}) by administering increasing dietary levels of histidine (0.23--1.27%) for 60 d. The concentration optimising final BW, SGR, FI, PER and FCR was 0.78% histidine. The next higher concentration tested (1.1%) significantly decreased those parameters (except FCR that increased). In a very similar study Feng et al. ([2013](#efs26072-bib-0038){ref-type="ref"}) -- using the same fish species and category, histidine levels and duration -- showed that levels of histidine around 0.86% improved the antioxidant capacity and inhibit lipid peroxidation and protein oxidation of juvenile Jian carp.

Han et al. ([2013](#efs26072-bib-0042){ref-type="ref"}) studied the effect of increasing dietary histidine (1.0, 1.5 and 1.9%) and arginine (1.71 and 2.75%) in a two‐factorial study on performance and blood parameters of Japanese flounder (*Paralichthys olivaceus*) juveniles when fed for 60 days. When arginine was low, BWG, final BW and SGR were higher at the highest level of histidine; and when arginine was high, these parameters were higher at the medium level of histidine, 1.9% histidine resulting in a reduction of these three performance parameters when compared with the medium level of histidine (1.5%). Serum glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) were affected by the different combinations of the two amino acids.

Li et al. ([2014](#efs26072-bib-0049){ref-type="ref"}) tested the effect of increasing dietary histidine (0.45--1.40%, six treatments with three replicates each) on performance of juvenile large yellow croaker (*Pseudosciaena crocea* R.) when fed for 51 days. Final weight and WG increased up to a dietary histidine concentration of 0.78%, decreasing significantly at the highest concentration.

Michelato et al. ([2016](#efs26072-bib-0051){ref-type="ref"}) studied the effect of increasing dietary histidine (0.42--1.15% dry diet. six treatments with three replicates each) on performance and blood parameters of juvenile (5 g initial BW) Nile tilapia (*Oreochromis niloticus*) when fed for 100 days. Final BW, BWG, FCR, PER and net protein utilisation were optimised in fish fed 0.89% histidine and those parameters significantly decreased (except for FCR that increased) at the highest histidine level. No differences were observed in blood parameters.

Although high levels of [l]{.smallcaps}‐histidine in feed (1.7%) are considered safe in Atlantic salmon (Breck et al., [2003](#efs26072-bib-0009){ref-type="ref"}, [2005a](#efs26072-bib-0010){ref-type="ref"},[b](#efs26072-bib-0011){ref-type="ref"}), the data above shows that levels even below this 1.7% can have adverse effects in other fish species.

Although there is limited evidence from the published literature on the effects of supplementing histidine levels above the requirements, the FEEDAP Panel considers that adverse effects might occur with levels of histidine in feeds exceeding the requirements, depending on the balance with other amino acids and the status of some essential trace elements such as copper and zinc (see Section [3.2.3](#efs26072-sec-0019){ref-type="sec"}).

The FEEDAP Panel notes that the number of fish species used in aquaculture is growing and is greater than the species reviewed above. The Panel further notes that for fish species other than salmonids, in very few cases there are histidine requirements established by internationally recognised scientific bodies (i.e. common carp, mrigal carp, rohu, Nile tilapia and channel catfish; NRC, [2011](#efs26072-bib-0054){ref-type="ref"}).

#### 3.2.3.3. Conclusions on safety for the target species {#efs26072-sec-0022}

The use of [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by fermentation using *E. coli* NITE SD 00268 is safe for salmonids and other fin fish when used as a nutritional additive to supplement the diet in appropriate amounts to cover the requirements, depending on the species, the physiological state of the animal, the performance level, the environmental conditions, the background amino acid composition of the unsupplemented diet and the status of some essential trace elements such as copper and zinc.

The FEEDAP Panel considers the maximum total concentration of 1.7% histidine in feed for salmonids proposed by the applicant as safe. For other fin fish species, the level of 1.7% appears to cause adverse effects. It is not possible to define a maximum safe concentration of histidine in fish other than salmonids as it depends on histidine nutritional requirements in the different fish species.

### 3.2.4. Safety for the consumer {#efs26072-sec-0023}

In the former opinion, the FEEDAP Panel considered that the use of the additive in animal nutrition would not represent a risk for the consumer.

No specific literature review was performed for the safety of the authorised additive for the consumer. The literature search conducted by the applicant to support the safety of the use of the authorised additive in salmonids did not provide any significant information on potential new issues related to safety for the consumer except for concentrations of histidine and related compounds in flesh reported in two studies (Breck et al., [2005b](#efs26072-bib-0011){ref-type="ref"}; Remø et al., [2014](#efs26072-bib-0057){ref-type="ref"}) that are described in Section [3.2.4.1](#efs26072-sec-0024){ref-type="sec"}.[43](#efs26072-note-1043){ref-type="fn"}

The product under assessment is produced by fermentation using a non‐genetically modified strain of *E. coli* W type derivative that is considered safe (see Section [3.1.1](#efs26072-sec-0010){ref-type="sec"}). No cells of the production strain were found in the final product. The FEEDAP Panel considers that no safety concerns would derive from the fermentation process. The additive contains ≥ 98% [l]{.smallcaps}‐histidine HCl monohydrate and the amount of unidentified material is \< 1%.

The FEEDAP Panel, however, is aware that the intake of histamine, a metabolic by‐product of histidine, through fish flesh following microbial spoilage is a serious concern for consumers (EFSA BIOHAZ Panel, [2011](#efs26072-bib-0020){ref-type="ref"}). Histamine poisoning from fish flesh has been called 'scombroid' poisoning because of the edible fish species (e.g. tuna, mackerel) more liable to histamine formation due to the high content of histidine in their flesh. Commission Regulation (EC) No 2073/2005 sets a maximum limit of 200 mg histamine/kg flesh for sea fishery products (raw fish at the point of the first sale) of fish species associated with a high amount of histidine, in particular fish species of the families Scombridae, Clupeidae, Engraulidae, Coryfenidae, Pomatomidae and Scombresosidae.[44](#efs26072-note-1044){ref-type="fn"}

Histamine is a biogenic amine that can be synthesised endogenously from histidine by a [l]{.smallcaps}‐histidine decarboxylase, and from histidine released from carnosine via carnosinase. Histamine can be metabolised either extracellularly by a diamino oxidase (DAO) present in the gut mucosa, or intracellularly by a histamine‐*N*‐methyltranferase (HNMT). As regards the exogenous production of histamine, many different bacterial species are known to possess histidine decarboxylase and have the ability to convert free histidine into histamine (Kanki et al., [2004](#efs26072-bib-0045){ref-type="ref"}; Emborg et al., [2006](#efs26072-bib-0033){ref-type="ref"}; Dalgaard et al., [2008](#efs26072-bib-0013){ref-type="ref"}).

The applicant reviewed the literature retrieved in relation to the search performed to support the safety of the additive for fish other than salmonids (see Section [3.2.3.2](#efs26072-sec-0021){ref-type="sec"}) to identify (a) studies in which levels of histidine and related substances were analysed in edible tissues of fish after supplementation with the amino acid and (b) information on histamine formation in fish flesh and the risk posed to consumers.[45](#efs26072-note-1045){ref-type="fn"} The outcome of the literature review and other relevant data are described and assessed below.

#### 3.2.4.1. Histidine intake and histidine deposition in animal tissues {#efs26072-sec-0024}

In a study with Atlantic cod (*Gadus morhua* L.) of 1.5 years of age (950 g initial BW), the effects of three dietary histidine levels (1.54, 2.74 and 6.34% of total histidine in diet, 2 replicates of 4 fish/treatment) on carcass characteristics (liquid leakage and fillet gaping during storage) were tested after feeding for 3 weeks (Førde‐Skjærvik et al., [2006](#efs26072-bib-0039){ref-type="ref"}). Histidine concentration in muscle significantly increased (260, 490 and 1,370 mg/kg muscle) in a dose dependent manner with histidine content in the diet. Anserine (1,620, 1,700 and 1,590 mg/kg muscle) was not significantly influenced by the diet. Carnosine was \< 50 mg/kg muscle for all groups.

Breck et al. ([2005b](#efs26072-bib-0011){ref-type="ref"}) studied the effect of dietary histidine and iron on cataract development of two strains of Atlantic salmon monitored through parr‐smolt transformation. Histidine diets (1.8% histidine in two treatments vs 1.2% histidine in control diet) fed for 26 weeks significantly increased histidine (2.7 vs 0.1 μmol/g of muscle, respectively), carnosine (0.60 vs 0.06 μmol/g of muscle, respectively) and anserine (16.1 vs 9.7 μmol/g of muscle, respectively) concentrations in fish flesh.

Remø et al. ([2014](#efs26072-bib-0057){ref-type="ref"}) fed diets containing increasing histidine concentrations (1, 1.2, 1.4, 1.6 and 1.8%) to Atlantic salmon (*Salmo salar* L.) smolts for 13 weeks after seawater transfer. Muscle histidine concentrations (at week 9: 0.1, 0.2, 1, 2.2 and 3.1 μmol/g of muscle, respectively)[46](#efs26072-note-1046){ref-type="fn"} reflected the increase of dietary histidine concentrations; and anserine (at week 9: 6, 12, 13.8, 14.2 and 14.3 μmol/g of muscle, respectively)[46](#efs26072-note-1046){ref-type="fn"} and carnosine (values per treatment not given) reached a plateau at different times.

There is a positive relationship between dietary histidine concentration and histidine and anserine deposition (Breck et al., [2005b](#efs26072-bib-0011){ref-type="ref"}; Remø et al., [2014](#efs26072-bib-0057){ref-type="ref"}), and carnosine deposition (Breck et al., [2005b](#efs26072-bib-0011){ref-type="ref"}) in fish flesh of Atlantic salmon. The scarce evidence in other fish species is limited to Atlantic cod (Førde‐Skjærvik et al., [2006](#efs26072-bib-0039){ref-type="ref"}) and suggests that supplementation with histidine significantly increases histidine deposition in flesh but the same effect was not observed in anserine concentrations and no data was available on carnosine concentrations.

#### 3.2.4.2. Histamine concentration in animal tissues in relation to dietary histidine {#efs26072-sec-0025}

As review by the BIOHAZ Panel ([2011](#efs26072-bib-0020){ref-type="ref"}), histamine poisoning is mainly related to fermented food of animal origin. The threshold for adverse health effects (acute reference dose) is 50 mg histamine per consumption for healthy individuals, and below detectable limits for individuals with histamine intolerance.

Limited data are available on the relationship between dietary histidine and histamine concentration in animal tissues. Although histidine is a precursor of histamine, the main factors influencing histamine formation in fish are storage time, temperature, pH, hygienic conditions (e.g. bacterial contamination, time to evisceration) or starter cultures of fermented foods, which have been reviewed in previous publications (EFSA BIOHAZ Panel, [2011](#efs26072-bib-0020){ref-type="ref"}; FAO, [2013](#efs26072-bib-0035){ref-type="ref"}, [2018](#efs26072-bib-0036){ref-type="ref"}; Technical report of EFSA, [2017](#efs26072-bib-0019){ref-type="ref"}). The literature search performed by the applicant retrieved scientific studies confirming that, more than the histidine content in diet, it is the amount of free histidine and carnosine in fish flesh and the bacterial spoilage that can increase histamine concentration in edible tissues/products from fish (Taylor et al., [1989](#efs26072-bib-0803){ref-type="ref"}; Lopez‐Sabater et al., [1996](#efs26072-bib-0050){ref-type="ref"}; Ababouch et al., [1991](#efs26072-bib-0001){ref-type="ref"}; Zarei et al., [2010](#efs26072-bib-0065){ref-type="ref"}; Boldyrev et al., [2013](#efs26072-bib-0008){ref-type="ref"}).[47](#efs26072-note-1047){ref-type="fn"}

As pointed out by FAO ([2018](#efs26072-bib-0036){ref-type="ref"}), 'the available evidence highlights that under appropriate time × temperature control, and within the sensory shelf‐life of the product, histamine development in Salmonidae to the levels that cause scombroid fish poisoning is unlikely to occur'.

In view of the above, the FEEDAP Panel considers that supplementing the diets of the target species with histidine to cover the requirements is unlikely to result in the increase of histamine formation provided that appropriate handling and storage of fish are ensured. Although there is no evidence from other aquaculture species, the Panel considers that the above conclusions can be extrapolated to other commonly farmed fish. For fish species associated with high levels of histidine in flesh,[48](#efs26072-note-1048){ref-type="fn"} the Panel notes that supplemental histidine may increase histidine concentration in fish flesh and the possibility to have higher levels of histamine in fish flesh following improper storage. However, there are limits established for histamine to protect the consumer, in particular for Scombroid fish species.

#### 3.2.4.3. Conclusions on safety for the consumer {#efs26072-sec-0026}

No new evidence on consumer safety has been provided that would make the FEEDAP Panel reconsider its previous conclusion. Thus, the FEEEDAP Panel confirms that the use of [l]{.smallcaps}‐histidine in salmonids production does not pose a risk for consumers.

[l]{.smallcaps}‐Histidine HCl monohydrate produced using *E. coli* NITE SD 00268 supplemented at levels appropriate to cover the nutritional requirements of fish other than salmonids is considered safe for the consumer.

### 3.2.5. Safety for user {#efs26072-sec-0027}

In the former opinion, no specific studies to support the safety of the additive for users/workers were submitted; the FEEDAP Panel noted that due to the long‐term use of comparable products as food supplements and cosmetic ingredients, specific risks were not expected. However, workers and users should wear protective clothes as recommended by the applicant (EFSA, [2005](#efs26072-bib-0014){ref-type="ref"}).

The applicant provided an *in vitro* study on skin irritation where histidine HCl monohydrate minimum 98% was tested. Additionally, the applicant performed a literature search for reports on toxicity of histidine by inhalation exposure.

#### 3.2.5.1. Safety for the respiratory system {#efs26072-sec-0028}

The particle size distribution showed that the additive has no particles \< 100 μm. However, the additive has high dusting potential (up to 5.8 g/m^3^). The particle size of the dust of the additive ranged from 2 to 32 μm diameter. The applicant reviewed the available literature in two adequate database platforms and searching for 'histidine AND inhalation toxicity' and no reports could be retrieved in relation to the toxicity of histidine by inhalation exposure.[49](#efs26072-note-1049){ref-type="fn"} The users are exposed by inhalation but due to lack of information on the potential inhalation toxicity of the additive, the FEEDAP Panel cannot draw a conclusion.

The bacterial endotoxin activity (analysed in three batches) was \< 100 IU/g. The scenario used to estimate the exposure of persons handling the additive to endotoxins in the dust, based on the EFSA guidance on user safety (EFSA FEEDAP Panel, [2012](#efs26072-bib-0022){ref-type="ref"}), is described in Appendix [A](#efs26072-sec-1001){ref-type="sec"}. The threshold for the quantity of inhaled endotoxins per working day is 900 IU, derived from the provisional occupational exposure limits given by the Dutch Expert Committee on Occupational Safety (Health Council of the Netherlands, [2010](#efs26072-bib-0043){ref-type="ref"}) and the UK Health and Safety Executive (HSE, [2013](#efs26072-bib-0044){ref-type="ref"}). Based on calculations of the content of endotoxins in dust, assuming a worst‐case scenario in which the amount of bacterial endotoxin activity is 99 IU/g, the estimated exposure would be 320 IU per eight‐hour working day, indicating no risk by inhalation due to exposure to endotoxins for people handling the additive.

#### 3.2.5.2. Safety for skin and eyes {#efs26072-sec-0029}

No information was made available to support the potential of the additive to be a skin sensitiser or irritant to eyes.

In an *in vitro* skin irritation reconstructed human epidermis test in accordance with OECD Guideline 439,[50](#efs26072-note-1050){ref-type="fn"} 16 mg of test sample were applied uniformly to cover the epidermis surface. After 42 min exposure at room temperature, the reconstructed skin models were rinsed and incubated for 42 h at 37°C. Subsequently each sample was incubated with 1 mg/mL 3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2*H*‐tetrazolium bromide (MTT) for 3 h at 37°C. The blue formazan generated was extracted and its optical density measured. Positive and negative controls performed as expected. The test item was classified as non‐irritant.

#### 3.2.5.3. Conclusions on safety for the user {#efs26072-sec-0030}

The additive is not a skin irritant. The additive is not hazardous by inhalation due to exposure to endotoxins for people handling the additive. In the absence of data, it is not possible to conclude on the potential of the additive to be toxic by inhalation, irritant to eyes or a skin sensitiser.

### 3.2.6. Safety for the environment {#efs26072-sec-0031}

In the previous opinion, the FEEDAP Panel concluded that the availability of the product would not adversely influence the environment because (i) the product replaces natural histidine sources, (ii) histidine from the product is highly absorbed and (iii) faecal histidine is rapidly degraded in the environment (EFSA, [2005](#efs26072-bib-0014){ref-type="ref"}).

The applicant did not provide any literature search to support the safety of the additive for the environment.

The amino acid [l]{.smallcaps}‐histidine is a physiological and natural component of animal and plant proteins. It is not excreted as such (but as urea/uric acid and carbon dioxide). The use of [l]{.smallcaps}‐histidine in animal nutrition would not lead to any localised increase in its concentration in the environment. The use of [l]{.smallcaps}‐histidine HCl monohydrate produced by *E. coli* NITE SD 00268 in animal nutrition is not expected to represent a risk to the environment.

3.3. Efficacy {#efs26072-sec-0032}
-------------

Efficacy studies are not required for amino acids naturally occurring in proteins of plants and animals. The nutritional role of the amino acid [l]{.smallcaps}‐histidine HCl monohydrate is well established in the scientific literature (NRC [1994](#efs26072-bib-0053){ref-type="ref"}, [2011](#efs26072-bib-0054){ref-type="ref"}, [2012](#efs26072-bib-0055){ref-type="ref"}).

In general, the product [l]{.smallcaps}‐histidine HCl monohydrate is considered an efficacious source of the essential amino acid [l]{.smallcaps}‐histidine for salmonids and other fin fish.

3.4. Post‐market monitoring {#efs26072-sec-0033}
---------------------------

The FEEDAP Panel considers that there is no need for specific requirements for a post‐market monitoring plan other than those established in the Feed Hygiene Regulation[51](#efs26072-note-1051){ref-type="fn"} and Good Manufacturing Practice.

4. Conclusions {#efs26072-sec-0034}
==============

The applicant has provided evidence that the composition of the additive currently in the market complies with the conditions of authorisation. The production strain has been modified by conventional mutagenesis and it does not raise safety concerns.

The use of [l]{.smallcaps}‐histidine monohydrochloride monohydrate produced by fermentation using *E. coli* NITE SD 00268 is safe for salmonids and other fin fish when used as a nutritional additive to supplement the diet in appropriate amounts to cover the requirements, depending on the species, the physiological state of the animal, the performance level, the environmental conditions, the background amino acid composition of the unsupplemented diet and the status of some essential trace elements such as copper and zinc. The FEEDAP Panel considers the maximum total concentration of 1.7% histidine in feed for salmonids proposed by the applicant as safe. For other fin fish species, the level of 1.7% appears to cause adverse effects. Therefore, it is not possible to define a maximum concentration of histidine in fish other than salmonids as it depends on histidine nutritional requirements in the different fish species.

The use of the authorised additive in salmonids production does not pose a risk for consumers, and the proposed maximum total concentration of 1.7% histidine in feed is considered safe for the consumer. [l]{.smallcaps}‐Histidine HCl monohydrate produced using *E. coli* NITE SD 00268 supplemented at levels appropriate to cover the nutritional requirements of fish other than salmonids is considered safe for the consumer.

The additive under assessment is not a skin irritant. In the absence of data, it is not possible to conclude on the potential of the additive to be toxic by inhalation, irritant to eyes or a skin sensitiser.

The amino acid [l]{.smallcaps}‐histidine is a natural component of plants and animals. The use of the additive under assessment in animal nutrition does not represent a risk to the environment.

The additive is considered an efficacious source of the amino acid [l]{.smallcaps}‐histidine for fish species.

5. Recommendation {#efs26072-sec-0035}
=================

Further research and monitoring activities on the levels of free histidine and dipeptides (carnosine) -- which are precursors for the biogenic amine histamine -- is recommended, aiming to set the safety criteria for fish and fishery products from farmed species other than salmonids, not covered in the Commission Regulation No 2073/2005.

6. Documentation as provided to EFSA / Chronology {#efs26072-sec-0036}
=================================================

DateEvent21/03/2016Dossier received by EFSA: L‐Histidine monohydrochloride monohydrate -- 98%, produced by *E. coli*. Submitted by Kyowa Hakko Europe GmbH.22/04/2016Reception mandate from the European Commission22/07/2016Application validated by EFSA -- Start of the scientific assessment14/10/2016Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 -- Scientific assessment suspended. *Issues: characterisation of the additive and the production strain, production process, stability, safety*.21/07/2017Reception of supplementary information from the applicant ‐ Scientific assessment re‐started22/09/2017Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 -- Scientific assessment suspended. *Issues: characterisation of the production strain*.16/10/2017Reception of supplementary information from the applicant ‐ Scientific assessment re‐started29/11/2017Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 -- Scientific assessment suspended. *Issues: characterisation of the additive and of the production strain; safety for the target species*.23/01/2018Reception of supplementary information from the applicant ‐ Scientific assessment re‐started18/03/2020Opinion adopted by the FEEDAP Panel. End of the Scientific assessment

DateEvent19/07/2018Dossier received by EFSA: L‐Histidine monohydrochloride monohydrate (98%) for minor species --other fin fish. Submitted by Kyowa Hakko Europe GmbH.06/07/2018Reception mandate from the European Commission20/08/2018Application validated by EFSA -- Start of the scientific assessment12/10/2018Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 -- Scientific assessment suspended. *Issues: Characterisation of the additive, conditions of use, safety for the target species, safety for the consumer, safety for the user, characterisation of the production strain*.20/11/2018Comments received from Member States26/03/2019Reception of supplementary information from the applicant ‐ Scientific assessment re‐started04/08/2019Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation (EC) No 1831/2003 -- Scientific assessment suspended. *Issues: Characterisation of the production strain*03/01/2020Reception of supplementary information from the applicant ‐ Scientific assessment re‐started14/02/2020Spontaneous submission of supplementary information19/02/2020Clarifications on the conditions of use provided by e‐mail18/03/2020Opinion adopted by the FEEDAP Panel. End of the Scientific assessment

Abbreviations {#efs26072-sec-0037}
=============

AFCEFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with FoodBEQbioanalytical equivalentsBWbody weightBWGbody weight gainCASChemical Abstracts ServiceCEFEFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing AidsCFUcolony forming unitCVcoefficient of variationDAOdiamino oxidaseDMdry matterEINECSEuropean Inventory of Existing Commercial Chemical SubstancesEURLEuropean Union Reference LaboratoryFCRfeed conversion ratioFIfeed intakeGOTglutamic oxaloacetic transaminaseGPTglutamic pyruvic transaminaseHNMThistamine‐*N*‐methyltranferaseIUPACInternational Union of Pure and Applied ChemistryJECFAthe Joint FAO/WHO Expert Committee on Food AdditivesLODlimit of detectionLOQlimit of quantificationMICminimum inhibitory concentrationMTT3‐(4,5‐dimethyl‐2‐thiazolyl)‐2,5‐diphenyl‐2*H*‐tetrazolium bromideNITEJapanese National Institute of Technology and EvaluationNRCNational Research CouncilPCBpolychlorinated biphenylPCDD/Fpolychlorinated dibenzo‐*p*‐dioxins and dibenzofuransPCRpolymerase chain reactionPERprotein efficiency ratioSGRspecific growth ratio

Appendix A -- Safety for the user {#efs26072-sec-1001}
=================================

 {#efs26072-sec-0038}

The effects of the endotoxin inhalation and the exposure limits have been described in a previous opinion (EFSA FEEDAP Panel, 2015).

**Calculation of maximum acceptable levels of exposure from feed additives**

The likely exposure time according to EFSA guidance (EFSA FEEDAP Panel, [2012](#efs26072-bib-0022){ref-type="ref"}) for additives added in premixtures assumes a maximum of 40 periods of exposure per day, each comprising 20 s, equal to = 800 s/day. With an uncertainty factor of 2, maximum inhalation exposure would occur for 2 × 800 = 1,600 s (0.444 h per day). Again, assuming a respiration volume of 1.25 m^3^/h, the inhalation volume providing exposure to potentially endotoxin‐containing dust would be 0.444 × 1.25 = 0.556 m^3^/day. This volume should contain no more than 900 IU endotoxin, so the dust formed from the product should contain no more than 900/0.556 = [1,619 IU/m]{.ul} ^[3]{.ul}^.

**Calculation of endotoxin content of dust**

Two key measurements are required to evaluate the potential respiratory hazard associated with endotoxin content of the product (the dusting potential of the product, expressed in g/m^3^; the endotoxin activity of the dust, determined by the *Limulus* amoebocyte lysate assay (expressed in IU/g)). If data for the dust are not available, the content of endotoxins of the product can be used instead. If the content of endotoxins of the relevant additive is *a* IU/g and the dusting potential is *b* g/m^3^, then the content of endotoxins of the dust, *c* IU/m^3^, is obtained by the simple multiplication *a* × *b*. This resulting value is further used for calculation of potential inhalatory exposure by users to endotoxin from the additive under assessment (Table [A.1](#efs26072-tbl-0001){ref-type="table"}) (EFSA FEEDAP Panel, [2012](#efs26072-bib-0022){ref-type="ref"}).

###### 

Estimation of user exposure to endotoxins from the additive [l]{.smallcaps}‐histidine HCl monohydrate produced by *Escherichia coli* NITE SD 00268, including consideration of using filter half mask (FF P2 or FF P3)[52](#efs26072-note-1055){ref-type="fn"} as a preventative measure

  Calculation   Identifier   Description                                                                                              Amount    Source
  ------------- ------------ -------------------------------------------------------------------------------------------------------- --------- --------------------------------------------------------------------------------
                *a*          Endotoxin content IU/g product                                                                           99        Technical dossier
                *b*          Dusting potential (g/m^3^)                                                                               5.84      Technical dossier
  *a* × *b*     *c*          Endotoxin content in the air (IU/m^3^)                                                                   578       
                *d*          No of premixture batches made/working day                                                                40        EFSA FEEDAP Panel ([2012](#efs26072-bib-0022){ref-type="ref"})
                *e*          Time of exposure (s)/production of one batch                                                             20        EFSA FEEDAP Panel ([2012](#efs26072-bib-0022){ref-type="ref"})
  *d* × *e*     *f*          Total duration of daily exposure/worker (s)                                                              800       
                *g*          Uncertainty factor                                                                                       2         EFSA FEEDAP Panel ([2012](#efs26072-bib-0022){ref-type="ref"})
  *f × g*       *h*          Refined total duration of daily exposure (s)                                                             1,600     
  *h*/3 600     *i*          Refined total duration of daily exposure (h)                                                             0.44      
                *j*          Inhaled air (m^3^)/eight‐hour working day                                                                10        EFSA FEEDAP Panel ([2012](#efs26072-bib-0022){ref-type="ref"})
  *j*/8 × *i*   *k*          Inhaled air during exposure (m^3^)                                                                       0.56      
  *c* × *k*     *l*          **Endotoxin inhaled (IU) during exposure/eight‐hour working day**                                        **321**   
                *m*          Health‐based recommended exposure limit of endotoxin (IU/m^3^)/eight‐hour working day                    90        Health Council of the Netherlands ([2010](#efs26072-bib-0043){ref-type="ref"})
  *m* × *j*     *n*          **Health‐based recommended exposure limit of total endotoxin exposure (IU)/eight‐hour working day**      **900**   
  *l* /10                    Endotoxins inhaled (IU)/eight‐hour working day reduced by filter half mask FF P2 (reduction factor 10)   32        
  *l* /20                    Endotoxins inhaled (IU)/eight‐hour working day reduced by filter half mask FF P3 (reduction factor 20)   16        

John Wiley & Sons, Ltd
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